Works matching IS 00070920 AND DT 2024 AND VI 130 AND IP 7

Results: 17

Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1096, doi. 10.1038/s41416-023-02565-8
By:
- Lai, Ting-Yu;
- Chiang, Tsai-Chen;
- Lee, Chih-Yuan;
- Kuo, Ting-Chun;
- Wu, Chien-Hui;
- Chen, Yi-Ing;
- Hu, Chun-Mei;
- Maskey, Manjit;
- Tang, Shiue-Cheng;
- Jeng, Yung-Ming;
- Tien, Yu-Wen;
- Lee, Eva Y.-H. P.;
- Lee, Wen-Hwa
Publication type:
Article
Redefining cancer research for therapeutic breakthroughs.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1078, doi. 10.1038/s41416-024-02634-6
By:
- Yuzhalin, Arseniy E.
Publication type:
Article
Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1232, doi. 10.1038/s41416-024-02660-4
By:
- Tan, Q.;
- Joshua, A. M.;
- Saggar, J. K.;
- Yu, M.;
- Wang, M.;
- Kanga, N.;
- Zhang, J. Y.;
- Chen, X.;
- Wouters, B. G.;
- Tannock, I. F.
Publication type:
Article
Antibodies toward Na+,HCO3–-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1206, doi. 10.1038/s41416-024-02591-0
By:
- Axelsen, Trine V.;
- Olesen, Claus;
- Khan, Danish;
- Mohammadi, Ali;
- Bouzinova, Elena V.;
- Nielsen, Christine J. F.;
- Mele, Marco;
- Hauerslev, Katrine R.;
- Pedersen, Helene L.;
- Balling, Eva;
- Vahl, Pernille;
- Tramm, Trine;
- Christiansen, Peer M.;
- Boedtkjer, Ebbe
Publication type:
Article
A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1149, doi. 10.1038/s41416-024-02588-9
By:
- Holt, Simon;
- Verrill, Mark;
- Pettit, Laura;
- Rigg, Anna;
- Hickish, Tamas;
- Archer, Caroline;
- Dent, Jo;
- Dillon, Marianne;
- Nathan, Mark;
- Barthelmes, Ludger;
- Rehman, Shazza;
- Sharaiha, Yousef;
- Innis, Paige;
- Sai-Giridhar, Priya;
- Khawaja, Saira
Publication type:
Article
Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1221, doi. 10.1038/s41416-024-02598-7
By:
- Zhang, Lu;
- Zhang, Ruiyun;
- Jin, Di;
- Zhang, Tianxiang;
- Shahatiaili, Akezhouli;
- Zang, Jingyu;
- Wang, Lu;
- Pu, Yuanchun;
- Zhuang, Guanglei;
- Chen, Haige;
- Fan, Jinhai
Publication type:
Article
Shifting the paradigm in the management of early prostate cancer.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1075, doi. 10.1038/s41416-024-02641-7
By:
- Gnanapragasam, Vincent
Publication type:
Article
Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1166, doi. 10.1038/s41416-024-02594-x
By:
- Abrahão, Renata;
- Brunson, Ann;
- Ruddy, Kathryn J.;
- Li, Qian;
- Li, Judy;
- Ryder, Mabel M.;
- Chubak, Jessica;
- Nichols, Hazel B.;
- Sauder, Candice A. M.;
- Gray, Marlaine F.;
- Hahn, Erin E.;
- Wun, Ted;
- Keegan, Theresa H. M.
Publication type:
Article
Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1119, doi. 10.1038/s41416-024-02597-8
By:
- Moldvai, Dorottya;
- Sztankovics, Dániel;
- Dankó, Titanilla;
- Vetlényi, Enikő;
- Petővári, Gábor;
- Márk, Ágnes;
- Patonai, Attila;
- Végső, Gyula;
- Piros, László;
- Hosszú, Ádám;
- Pápay, Judit;
- Krencz, Ildikó;
- Sebestyén, Anna
Publication type:
Article
Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1196, doi. 10.1038/s41416-024-02584-z
By:
- Shah, Esha T.;
- Molloy, Christopher;
- Gough, Madeline;
- Kryza, Thomas;
- Samuel, Selwin G.;
- Tucker, Amos;
- Bhatia, Maneet;
- Ferguson, Genevieve;
- Heyman, Rebecca;
- Vora, Shivam;
- Monkman, James;
- Bolderson, Emma;
- Kulasinghe, Arutha;
- He, Yaowu;
- Gabrielli, Brian;
- Hooper, John D.;
- Richard, Derek J.;
- O'Byrne, Kenneth J.;
- Adams, Mark N.
Publication type:
Article
Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1109, doi. 10.1038/s41416-024-02595-w
By:
- Ye, Hai-Shan;
- Zhou, Dan;
- Li, Hong;
- Lv, Jin;
- Huang, Hui-Qi;
- She, Jia-Jun;
- Nie, Jun-Hua;
- Li, Ting-Ting;
- Lu, Meng-Di;
- Du, Bo-Le;
- Yang, Shu-Qing;
- Chen, Pei-Xian;
- Li, Sheng;
- Ye, Guo-Lin;
- Luo, Wei;
- Liu, Jia
Publication type:
Article
Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1083, doi. 10.1038/s41416-024-02576-z
By:
- Kanahori, Masaya;
- Shimada, Eijiro;
- Matsumoto, Yoshihiro;
- Endo, Makoto;
- Fujiwara, Toshifumi;
- Nabeshima, Akira;
- Hirose, Takeshi;
- Kawaguchi, Kengo;
- Oyama, Ryunosuke;
- Oda, Yoshinao;
- Nakashima, Yasuharu
Publication type:
Article
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1187, doi. 10.1038/s41416-024-02583-0
By:
- Hashimoto, Masashi;
- Kuroda, Shinji;
- Kanaya, Nobuhiko;
- Kadowaki, Daisuke;
- Yoshida, Yusuke;
- Sakamoto, Masaki;
- Hamada, Yuki;
- Sugimoto, Ryoma;
- Yagi, Chiaki;
- Ohtani, Tomoko;
- Kumon, Kento;
- Kakiuchi, Yoshihiko;
- Yasui, Kazuya;
- Kikuchi, Satoru;
- Yoshida, Ryuichi;
- Tazawa, Hiroshi;
- Kagawa, Shunsuke;
- Yagi, Takahito;
- Urata, Yasuo;
- Fujiwara, Toshiyoshi
Publication type:
Article
Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1176, doi. 10.1038/s41416-024-02579-w
By:
- Lin, Wanzun;
- Chen, Xiaochuan;
- Huang, Zongwei;
- Ding, Qin;
- Yang, Hanxuan;
- Li, Ying;
- Lin, Duo;
- Lin, Jun;
- Zhang, Haojiong;
- Yang, Xuelian;
- Li, Chao;
- Chen, Chuanben;
- Qiu, Sufang
Publication type:
Article
Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1141, doi. 10.1038/s41416-024-02580-3
By:
- Gaillard, Thomas;
- Piketty, Jeanne;
- Feron, Jean-Guillaume;
- Girard, Noemie;
- Pauly, Lea;
- Gauroy, Elodie;
- Darrigues, Lauren;
- Grandal, Beatriz;
- Pierga, Jean-Yves;
- Hamy-Petit, Anne-Sophie;
- Reyal, Fabien;
- Laas, Enora
Publication type:
Article
Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1157, doi. 10.1038/s41416-023-02540-3
By:
- Saito, Takuro;
- Kurokawa, Yukinori;
- Fujitani, Kazumasa;
- Kawabata, Ryohei;
- Takeno, Atsushi;
- Mikami, Jota;
- Endo, Shunji;
- Matsuyama, Jin;
- Akamaru, Yusuke;
- Hirota, Masashi;
- Kishi, Kentaro;
- Urakawa, Shinya;
- Yamamoto, Kei;
- Tanaka, Koji;
- Takahashi, Tsuyoshi;
- Oka, Mikio;
- Wada, Hisashi;
- Eguchi, Hidetoshi;
- Doki, Yuichiro
Publication type:
Article
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Published in:
British Journal of Cancer, 2024, v. 130, n. 7, p. 1131, doi. 10.1038/s41416-023-02436-2
By:
- Burris, Howard A.;
- Berlin, Jordan;
- Arkenau, Tobias;
- Cote, Gregory M.;
- Lolkema, Martijn P.;
- Ferrer-Playan, Jordi;
- Kalapur, Anup;
- Bolleddula, Jayaprakasam;
- Locatelli, Giuseppe;
- Goddemeier, Thomas;
- Gounaris, Ioannis;
- de Bono, Johann
Publication type:
Article

Works matching IS 00070920 AND DT 2024 AND VI 130 AND IP 7

Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors.

Redefining cancer research for therapeutic breakthroughs.

Retraction Note: Effect of pantoprazole to enhance activity of docetaxel against human tumour xenografts by inhibiting autophagy.

Antibodies toward Na<sup>+</sup>,HCO<sub>3</sub><sup>–</sup>-cotransporter NBCn1/SLC4A7 block net acid extrusion and cause pH-dependent growth inhibition and apoptosis in breast cancer.

A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer.

Synergistic induction of tertiary lymphoid structures by chemoimmunotherapy in bladder cancer.

Shifting the paradigm in the management of early prostate cancer.

Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas.

Inhibition of Aurora B kinase (AURKB) enhances the effectiveness of 5-fluorouracil chemotherapy against colorectal cancer cells.

Organoid forming potential as complementary parameter for accurate evaluation of breast cancer neoadjuvant therapeutic efficacy.

Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8<sup>+</sup> T cell infiltration.

Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus.

Identification of novel molecular subtypes to improve the classification framework of nasopharyngeal carcinoma.

Rethinking surgical revisions: impact of the MonarchE trial on axillary dissection in hormone-positive HER2-negative early breast cancer patients potentially eligible for abemaciclib.

Serum NY-ESO-1 antibody as a predictive biomarker for postoperative recurrence of gastric cancer: a multicenter prospective observational study.

A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.